Overview

Aliskiren and Renin Inhibition in Diastolic Heart Failure

Status:
Withdrawn
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to compare the effects that 2 different combinations of heart failure medications have on the levels of certain blood markers which cause and/or worsen heart failure. Additionally, the investigators will investigate any differences that may exist between Hispanics and Non-Hispanics. The investigators hope to find that Hispanic Americans will have a greater response to this new regimen compared to non-Hispanic Americans.
Phase:
N/A
Details
Lead Sponsor:
Texas Tech University Health Sciences Center
Treatments:
Lisinopril
Spironolactone